BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 3884243)

  • 1. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type A and type B toxins in stool samples of infants with botulism.
    Dezfulian M; Hatheway CL; Yolken RH; Bartlett JG
    J Clin Microbiol; 1984 Sep; 20(3):379-83. PubMed ID: 6490825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coproexamination for botulinal toxin and clostridium botulinum. A new procedure for laboratory diagnosis of botulism.
    Dowell VR; McCroskey LM; Hatheway CL; Lombard GL; Hughes JM; Merson MH
    JAMA; 1977 Oct; 238(17):1829-32. PubMed ID: 333132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantities of Clostridium botulinum organisms and toxin in feces and presence of Clostridium botulinum toxin in the serum of an infant with botulism.
    Paton JC; Lawrence AJ; Steven IM
    J Clin Microbiol; 1983 Jan; 17(1):13-5. PubMed ID: 6338033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitation of Clostridium botulinum organisms and toxin in the feces of an infant with botulism.
    Paton JC; Lawrence AJ; Manson JI
    J Clin Microbiol; 1982 Jan; 15(1):1-4. PubMed ID: 6764763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of Clostridium difficile toxin from Clostridium botulinum toxin by the mouse lethality test.
    Gilligan PH; Brown L; Berman RE
    Appl Environ Microbiol; 1983 Jan; 45(1):347-9. PubMed ID: 6824325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective isolation and rapid identification of Clostridium botulinum types A and B by toxin detection.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1985 Feb; 21(2):231-3. PubMed ID: 3882748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory aspects of infant botulism in California.
    Midura TF
    Rev Infect Dis; 1979; 1(4):652-5. PubMed ID: 399372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of feces and serum for diagnosis of infant botulism in 336 patients.
    Hatheway CL; McCroskey LM
    J Clin Microbiol; 1987 Dec; 25(12):2334-8. PubMed ID: 3323228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A.
    Notermans S; Dufrenne J; Schothorst M
    Jpn J Med Sci Biol; 1978 Feb; 31(1):81-5. PubMed ID: 351243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of monoclonal antibodies in enzyme linked immunosorbent assay (ELISA) for detection of botulinum type B toxins.
    Notermans S; Kozaki S; Kamata Y; Sakaguchi G
    Jpn J Med Sci Biol; 1984 Jun; 37(3):137-40. PubMed ID: 6389944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory diagnosis of botulism complicated by pyridostigmine treatment of the patient. A method for selectively removing interfering substances from clinical specimens.
    Horwitz MA; Hatheway CL; Dowell VR
    Am J Clin Pathol; 1976 Oct; 66(4):737-42. PubMed ID: 970375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical toxin variant of Clostridium botulinum type B associated with infant botulism.
    Hatheway CL; McCroskey LM; Lombard GL; Dowell VR
    J Clin Microbiol; 1981 Dec; 14(6):607-11. PubMed ID: 7037830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of Clostridium botulinum type A toxin and organisms in the feces of a case of infant botulism and examination of other related specimens.
    Takahashi M; Shimizu T; Ooi K; Noda H; Nasu T; Sakaguchi G
    Jpn J Med Sci Biol; 1988 Feb; 41(1):21-6. PubMed ID: 3057266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin.
    Notermans S; Dufrenne J; Kozaki S
    Appl Environ Microbiol; 1979 Jun; 37(6):1173-5. PubMed ID: 384908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme-linked immunosorbent assay (ELISA) for the detection and differentiation of Clostridium botulinum toxins type A and B.
    Michalik M; Grzybowski J; Ligieza J; Reiss J
    J Immunol Methods; 1986 Nov; 93(2):225-30. PubMed ID: 3095433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.